Treatment for Clostridium-difficile Infection With IMM529

Summary

This study will evaluate the safety and tolerability of IMM-529 together with standard of care (SOC) in patients with Clostridium-difficile Infection.

Timeline

Start

2017-09-01

Primary completion

2019-11-07

Completion

2019-11-07

Outcome

Outcome not reported

Stopped (Enrollment): “Study was stopped due to slow recruitment. All subjects completed their participation including follow up period per protocol. No safety issues.”

Drugs

Indications